Drawing for OCCLUTECH EVERY BEAT COUNTS.

USPTO serial 98689502

OCCLUTECH EVERY BEAT COUNTS.

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WELCH, KATHERINE E
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with OCCLUTECH EVERY BEAT COUNTS.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alison W. Jarzyna

Sarah G. Voeller Larkin Hoffman Daly & Lindgren Ltd.8300 Norman Center Drive, Suite 1000Minneapolis, MN 55437United States

Goods and services

ClassDescriptionStatusFirst use
010Medical apparatus for treating congestive heart failure and replacement parts therefor; Medical implants consisting of artificial materials; Medical implants comprising natural, non-living materials; Surgical instruments and apparatus for medical and veterinary use, and replacement parts therefor; medical apparatus and instruments for use in surgery, and replacement parts therefor; surgical instruments and apparatus for medical, or veterinary use, namely, septal defect occluders, cardiac occluders, vascular occluders, stents and vascular and cardiovascular plugs for use in cardiovascular surgery or interventions, vascular surgery or interventions and intravascular surgery or interventions; surgical implants comprising artificial material for use in cardiovascular surgery or interventions, vascular surgery or interventions and endovascular surgery or interventions; medical devices for implanting vascular and cardiovascular implants composed of artificial materials, stents including arterial, venous and renal stents, occluders, artificial valves, vascular and cardiovascular devices for treating arrhythmias; implantable medical devices, namely, vascular and cardiovascular implants composed of artificial materials, stents including arterial, venous and renal stents, septal defect occluders, cardiac occluders, vascular occluders, artificial valves, vascular and cardiovascular devices for treating arrhythmias; stents; Septal defect occluders; Cardiac occluders; Vascular occluders; disposable medical products, namely, catheters, intravascular delivery sheaths, hemostasis valves for intravascular delivery sheaths, cardiovascular dilators for intravascular delivery sheaths, loaders for loading septal defect occluders, cardiac occluders, vascular occluders, vascular and cardiovascular plugs, stents, artificial valves, vascular and cardiovascular devices for treating arrhythmias into intravascular delivery sheaths, sizing balloons for measuring cardiovascular defects; medical apparatus and instruments, namely, septal defect occluders, cardiac occluders, vascular occluders and vascular and cardiovascular plugs; medical devices for use in interventional procedures, namely, implantable devices which are particularly well-suited for delivery through a catheter for implantation in a patient's heart, vessels or other places in a patient's body, namely, stents, occluders, vascular and cardiovascular plugs, all of the aforementioned consisting of artificial and natural, non-living materialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 24, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 24, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 22, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 21, 2026EX1GSOU EXTENSION 1 GRANTED—
Jan 21, 2026EXT1SOU EXTENSION 1 FILED—
Jan 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 21, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Jan 21, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 21, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 21, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 22, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 27, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 27, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 21, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 29, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Apr 29, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 29, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 29, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 5, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 24, 2025DOCKASSIGNED TO EXAMINER—
Feb 23, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 12, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance